%0 Journal Article
%T Nordic guidelines 2021 for diagnosis and treatment of gastroenteropancreatic neuroendocrine neoplasms.
%A Janson ET
%A Knigge U
%A Dam G
%A Federspiel B
%A Grønbaek H
%A Stålberg P
%A Langer SW
%A Kjaer A
%A Arola J
%A Schalin-Jäntti C
%A Sundin A
%A Welin S
%A Thiis-Evensen E
%A Sorbye H
%J Acta Oncol
%V 60
%N 7
%D Jul 2021
%M 33999752
%F 4.311
%R 10.1080/0284186X.2021.1921262
%X UNASSIGNED: The diagnostic work-up and treatment of patients with gastroenteropancreatic (GEP) neuroendocrine neoplasms (NEN) has undergone major advances and new methods are introduced. Furthermore, an update of the WHO classification has resulted in a new nomenclature for GEP-NEN that is implemented in the clinic.
UNASSIGNED: These Nordic guidelines summarise the Nordic Neuroendocrine Tumour Group's current view on how to diagnose and treat GEP-NEN patients and aims to be useful in the daily practice for clinicians.